1163264

Dapagliflozin Related Compound A

United States Pharmacopeia (USP) Reference Standard

• 別名: (2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3, 4,5-triol
• 実験式（ヒル表記法）: C₂₁H₂₅BrO₆
• CAS番号: 1807632-95-6
• 分子量: 453.32
• MDL number: MFCD34472660
• NACRES: NA.24
• UNSPSC Code: 41116107
• eCl@ss: 25140904

特性

• grade: pharmaceutical primary standard
• agency: USP
• API family: dapagliflozin
• packaging: pkg of 15 mg
• manufacturer/tradename: USP
• application(s): pharmaceutical; pharmaceutical (small molecule); pharmaceutical
• format: neat
• storage temp.: room temp

詳細

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Dapagliflozin Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Also, for use with USP monographs such as Dapagliflozin Propanediol

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS07,GHS09
• 注意喚起語: Danger
• ハザードコード: H302,H319,H372,H411
• 注意事項: P260 - P264 - P273 - P301 + P312 - P305 + P351 + P338 - P314
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - STOT RE 1
• 標的臓器: Kidney
• 保管分類: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 2
• 引火点 (F): Not applicable
• 引火点（°C）: Not applicable